Strattera Dosing for 100 lb 15-Year-Old
For a 15-year-old weighing 100 lbs (45.4 kg), start Strattera at approximately 40 mg once daily in the morning, then titrate to a target dose of approximately 54 mg/day (1.2 mg/kg/day) after a minimum of 3 days, with a maximum dose not exceeding 63 mg/day (1.4 mg/kg/day or 100 mg/day, whichever is lower). 1
Dosing Algorithm
Initial Dosing:
- Starting dose: 0.5 mg/kg/day × 45.4 kg = ~23 mg/day (round to available capsule strength: 25 mg)
- Alternative conservative start: 40 mg once daily (approximately 0.9 mg/kg/day)
- Administer as a single morning dose or split into morning and late afternoon/evening doses 1
Titration Schedule:
- Wait minimum 3 days at starting dose before increasing 2
- Target dose: 1.2 mg/kg/day × 45.4 kg = 54 mg/day (use 60 mg capsule as closest available strength)
- This target dose has demonstrated optimal efficacy without additional benefit from higher doses 2, 3
Maximum Dose:
- Absolute maximum: 1.4 mg/kg/day × 45.4 kg = 63.6 mg/day, not to exceed 100 mg/day 1
- The 1.8 mg/kg/day dose (82 mg for this patient) provides no additional benefit over 1.2 mg/kg/day 2, 3
Critical Safety Monitoring
Before Starting Treatment:
- Obtain detailed cardiac history: personal symptoms (chest pain, syncope, palpitations) and family history of sudden cardiac death, Wolff-Parkinson-White syndrome, hypertrophic cardiomyopathy, long QT syndrome 4
- Baseline vital signs, height, and weight 4
- Black Box Warning: Monitor closely for suicidal ideation, especially during the first few months and at dose changes 1, 2
Ongoing Monitoring:
- Weekly contact during titration phase (2-4 weeks) 5
- Monthly appointments until symptoms stabilized 5
- Assess for common adverse effects: nausea, vomiting, fatigue, decreased appetite, abdominal pain, somnolence 1
- Weight at each visit to monitor appetite suppression 2
Important Clinical Considerations
Dosing Flexibility:
- If gastrointestinal side effects occur, split the total daily dose into morning and evening administration 1
- Evening-only dosing is an option if daytime sedation is problematic 1
- Effects typically not observed until 6-12 weeks after initiation, unlike stimulants 1
Drug Interactions:
- If patient is taking CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine), initial target should be 0.5 mg/kg/day with slower titration 1
- Poor metabolizers (7% of population) have 10-fold higher drug levels and require dose adjustment 2
Growth Effects:
- Weight and height gain may lag behind normative data for first 9-12 months, then rebounds 2
- After 3 years, patients typically gain 0.5 kg more than predicted but 0.4 cm less in height 2
When to Consider Atomoxetine First-Line:
- Comorbid tic disorders or Tourette's syndrome 1
- Substance use disorder concerns 1
- Stimulant intolerance or inadequate response 1
- Need for 24-hour symptom coverage 1
Common Pitfalls to Avoid
- Don't exceed 1.2 mg/kg/day initially - the 1.8 mg/kg/day dose shows no additional efficacy and may increase side effects 2, 3
- Don't expect rapid response - unlike stimulants, full therapeutic effect requires 6-12 weeks 1
- Don't abruptly discontinue - taper if stopping, though withdrawal syndrome is not typical 6
- Don't ignore cardiovascular screening - obtain cardiac history before initiating 4
- Don't miss suicidality monitoring - this is a black box warning requiring vigilant assessment 1, 2